
Thursday, April 14, 2022 2:34:17 PM
April 11 2022 - 03:35AM
Dow Jones News
Norwegian energy group Equinor ASA said Monday that it has made an oil and gas discovery close to the Troll and Fram fields in the North Sea.
As the operator of production license 293 B Equinor said, based on preliminary estimates, the size of the discovery is between 4 million and 8 million standard cubic meters of recoverable oil equivalent, or 25 million-50 million barrels of recoverable oil equivalent.
Temporarily called Kveikje, this is the sixth discovery in this area since the fall of 2019. Over 300 million barrels of oil equivalent were proven in the five former discoveries, it said.
"As we did with the other discoveries in this area, we will consider tying this discovery to the Troll B or C platform," Lill H. Brusdal, Equinor's vice president for the Troll area, said.
"By utilising the existing infrastructure, we will be able to recover these volumes at a low cost and with low emissions."
Equinor plans to drill another exploration well in the area this year, the company said.
The owners of license 293 B include Equinor with a 51% stake, DNO ASA with 29%, Idemitsu Kosan Co. with 10%, and Longboat Energy PLC with 10%.
Recent EQNR News
- Equinor Falls Short of Q2 Earnings Forecast as Output and Energy Prices Decline • IH Market News • 07/08/2025 01:23:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/08/2025 10:05:08 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/02/2025 10:05:05 AM
- Equinor ASA: Completed share capital reduction • GlobeNewswire Inc. • 07/02/2025 06:01:36 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/01/2025 10:05:07 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/24/2025 12:16:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2025 11:02:20 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/17/2025 10:57:27 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/10/2025 11:22:29 AM
- Election to Equinor's board of directors • GlobeNewswire Inc. • 06/02/2025 03:27:58 PM
- Equinor ASA: Execution of debt capital market transactions • GlobeNewswire Inc. • 05/27/2025 09:09:44 PM
- Recommendation from Equinor's nomination committee • GlobeNewswire Inc. • 05/26/2025 06:02:00 AM
- Equinor ASA: Announcement of cash dividend per share in NOK for fourth quarter 2024 • GlobeNewswire Inc. • 05/22/2025 05:50:00 AM
- Equinor ASA: Ex. dividend fourth quarter 2024 today – OSE • GlobeNewswire Inc. • 05/15/2025 05:50:00 AM
- Equinor ASA: Minutes from the annual general meeting 2025 • GlobeNewswire Inc. • 05/14/2025 06:33:12 PM
- Equinor sells the Peregrino field for USD 3.5 billion • GlobeNewswire Inc. • 05/02/2025 12:29:04 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2025 12:02:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2025 11:09:46 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2025 10:05:44 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2025 10:04:49 AM
- Equinor to commence second tranche of the 2025 share buy-back programme • GlobeNewswire Inc. • 04/30/2025 04:48:17 AM
- Equinor ASA: Key information relating to cash dividend for first quarter 2025 • GlobeNewswire Inc. • 04/30/2025 04:46:59 AM
- Equinor first quarter 2025 results • GlobeNewswire Inc. • 04/30/2025 04:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/23/2025 10:10:12 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/22/2025 11:15:13 AM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM